The invention relates to novel compounds which show high affinity for cocain e receptors in the brain, particularly dopamine and serotonin transporter sites. The compounds may be used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases.
COCAINE RECEPTOR BINDING LIGANDS